miRNA-mediated risk for schizophrenia in 22q11.2 deletion syndrome

In humans, the most common genomic disorder is a hemizygous deletion of a 1.5–3 Mb region of chromosome 22q11.2. The resultant 22q11.2 deletion syndrome (22q11.2DS) can affect multiple organ systems, and most notably includes cardiac, craniofacial, and neurodevelopmental defects. Individuals with 22q11.2DS have a 20–25-fold risk of developing schizophrenia compared to individuals from the general population, making 22q11.2DS the strongest known molecular genetic risk factor for schizophrenia. Although the deleted region includes DGCR8, a gene coding for a miRNA processing protein, the exact mechanism by which this deletion increases risk is unknown. Importantly, several lines of evidence suggest that miRNAs may modulate risk for schizophrenia in other, non-22q11.2DS populations. Here we present a theory which mechanistically explains the link between 22q11.2DS, miRNAs, and schizophrenia risk. We outline the testable predictions generated by this theory and present preliminary data in support of our model. Further experimental validation of this model could provide important insights into the etiology of both 22q11.2DS and more common forms of schizophrenia.

[1]  Aaron T. Smith,et al.  Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for primary microRNA processing , 2012, Proceedings of the National Academy of Sciences.

[2]  Noam Shomron,et al.  Canalization of development by microRNAs , 2006, Nature Genetics.

[3]  L. Tsai,et al.  Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets , 2013, Molecular Psychiatry.

[4]  T. Insel.  Rethinking schizophrenia , 2010, Nature.

[5]  R. Ophoff,et al.  Association of the PIK4CA schizophrenia‐susceptibility gene in adults with the 22q11.2 deletion syndrome , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[6]  A. LaMantia,et al.  Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: Patterning, proliferation, and mitochondrial functions of 22q11 genes , 2011, International Journal of Developmental Neuroscience.

[7]  C. Linder.  Genetic variables that influence phenotype. , 2006, ILAR journal.

[8]  Veronica J Vieland,et al.  Thermometers: Something for Statistical Geneticists to Think about , 2006, Human Heredity.

[9]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[10]  E. Ullian,et al.  A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing. , 2011, RNA.

[11]  D. Kleinjan,et al.  Cis-ruption mechanisms: disruption of cis-regulatory control as a cause of human genetic disease. , 2009, Briefings in functional genomics & proteomics.

[12]  Dhavendra Kumar.  Disorders of the genome architecture: a review , 2008, Genomic Medicine.

[13]  E. Zackai,et al.  Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis. , 1993, Journal of medical genetics.

[14]  Dai Zhang,et al.  Systematic association analysis of microRNA machinery genes with schizophrenia informs further study , 2012, Neuroscience Letters.

[15]  Robert Blelloch,et al.  Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. , 2008, Genes & development.

[16]  Vernell S. Williamson,et al.  Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137 , 2012, Schizophrenia Research.

[17]  A. Bassett,et al.  Schizophrenia and 22q11.2 deletion syndrome , 2008, Current psychiatry reports.

[18]  A. Bassett,et al.  Elevated prevalence of generalized anxiety disorder in adults with 22q11.2 deletion syndrome. , 2010, The American journal of psychiatry.

[19]  Gene W. Yeo,et al.  Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans , 2010, Nature Structural &Molecular Biology.

[20]  Mary Goldman,et al.  The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..

[21]  V. Vieland,et al.  Statistical Evidence: A Likelihood Paradigm , 1998 .

[22]  E. Zackai,et al.  Prevalence of 22 q 1 1 microdeletions in DiGeorge and velocardiofacial syndromes : implications for genetic counselling and prenatal diagnosis , 2022 .

[23]  Murray J. Cairns,et al.  MicroRNA dysregulation in schizophrenia , 2012, Neurobiology of Disease.

[24]  Yungui Huang,et al.  Association statistics under the PPL framework , 2010, Genetic epidemiology.

[25]  Alberto Maria Segre,et al.  Exploiting gene × gene interaction in linkage analysis , 2007, BMC proceedings.

[26]  Jian Huang,et al.  Comparison of ‘Model-Free’ and ‘Model-Based’ Linkage Statistics in the Presence of Locus Heterogeneity: Single Data Set and Multiple Data Set Applications , 2001, Human Heredity.

[27]  Ümit V. Çatalyürek,et al.  KELVIN: A Software Package for Rigorous Measurement of Statistical Evidence in Human Genetics , 2011, Human Heredity.

[28]  A. Mele,et al.  Ago HITS-CLIP decodes miRNA-mRNA interaction maps , 2009, Nature.

[29]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[30]  Alistair T. Pagnamenta,et al.  Novel method for combined linkage and genome-wide association analysis finds evidence of distinct genetic architecture for two subtypes of autism , 2011, Journal of Neurodevelopmental Disorders.

[31]  R. Weksberg,et al.  Catechol-O-methyl Transferase and Expression of Schizophrenia in 73 Adults with 22q11 Deletion Syndrome , 2007, Biological Psychiatry.

[32]  Mark J. Bowser,et al.  Genotype and cardiovascular phenotype correlations with TBX1 in 1,022 velo‐cardio‐facial/digeorge/22q11.2 deletion syndrome patients , 2011, Human mutation.

[33]  Scott B. Dewell,et al.  Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA Target Sites by PAR-CLIP , 2010, Cell.

[34]  David Haussler,et al.  The UCSC genome browser database: update 2007 , 2006, Nucleic Acids Res..

[35]  Hui Zhou,et al.  starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..

[36]  R. Biggar,et al.  The risk of human immunodeficiency virus-1 infection in twin pairs born to infected mothers in Africa. , 2003, The Journal of infectious diseases.

[37]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[38]  B. Roe,et al.  Chromosome 22-specific low copy repeats and the 22q11.2 deletion syndrome: genomic organization and deletion endpoint analysis. , 2000, Human molecular genetics.

[39]  V. Vieland,et al.  Accumulating quantitative trait linkage evidence across multiple datasets using the posterior probability of linkage , 2007, Genetic epidemiology.

[40]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[41]  I. Cross,et al.  A population study of chromosome 22q11 deletions in infancy , 1998, Archives of disease in childhood.

[42]  Joseph A. Gogos,et al.  Strong association of de novo copy number mutations with sporadic schizophrenia , 2008, Nature Genetics.

[43]  V. Vieland,et al.  Performance comparison of two-point linkage methods using microsatellite markers flanking known disease locations , 2005, BMC Genetics.

[44]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.

[45]  B. Morrow,et al.  Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. , 1999, American journal of human genetics.

[46]  Richard David-Rus,et al.  Altered MicroRNA Expression Profiles in Postmortem Brain Samples from Individuals with Schizophrenia and Bipolar Disorder , 2011, Biological Psychiatry.

[47]  K. Devriendt,et al.  Practical guidelines for managing patients with 22q11.2 deletion syndrome. , 2011, The Journal of pediatrics.

[48]  M. Sur,et al.  The Emerging Role of microRNAs in Schizophrenia and Autism Spectrum Disorders , 2012, Front. Psychiatry.

[49]  H. Saito,et al.  MicroRNAs in cancers and neurodegenerative disorders , 2012, Front. Gene..

[50]  Jian Huang,et al.  Power to Detect Linkage Based on Multiple Sets of Data in the Presence of Locus Heterogeneity: Comparative Evaluation of Model-Based Linkage Methods for Affected Sib Pair Data , 2001, Human Heredity.

[51]  Paul Pavlidis,et al.  Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model , 2008, Nature Genetics.